Doctor Michael L. Titzer, MD works in the field of Hematology. He studied medicine at Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care Michael Titzer is a published physician. He published 2 publications, including: 'Gefitinib plus celecoxib in chemotherapy-nave patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group.' Michael Titzer accepts Medicare payments and is listed with Medicare.gov.
|
Dr. Sheryl L. Ziegler, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Vivian C. Cook, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark D. Browning, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Maqbool Ahmed, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Karim Anwar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Anthony W. Stephens, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward P. Fox, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas M. Waits, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Sheryl L. Ziegler, DO
|
|
Dr. Arshad I. Husain, MD
This Doctor is OpenDoctor Recommended.
|